Fidelity Investments
ZVRA icon

Fidelity Investments’s Zevra Therapeutics ZVRA Stock Holding History

Fidelity Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.9M Buy
3,211,877
+818,384
+34% +$7.38M ﹤0.01% 1618
2025
Q4 		$21.4M Buy
2,393,493
+758,922
+46% +$7.18M ﹤0.01% 1752
2025
Q3 		$15.5M Sell
1,634,571
-654,672
-29% -$6.57M ﹤0.01% 1833
2025
Q2 		$20.2M Sell
2,289,243
-17,074
-0.7% -$139K ﹤0.01% 1695
2025
Q1 		$17.3M Sell
2,306,317
-23,026
-1% -$183K ﹤0.01% 1733
2024
Q4 		$19.4M Buy
2,329,343
+16,141
+0.7% +$138K ﹤0.01% 1737
2024
Q3 		$16.1M Buy
2,313,202
+2,312,384
+282,688% +$15.7M ﹤0.01% 1785
2024
Q2 		$4.01K Sell
818
-333
-29% -$1.58K ﹤0.01% 4611
2024
Q1 		$6.67K Sell
1,151
-101
-8% -$621 ﹤0.01% 4417
2023
Q4 		$8.2K Sell
1,252
-3,660
-75% -$17.1K ﹤0.01% 4296
2023
Q3 		$23.7K Buy
4,912
+4,088
+496% +$20.4K ﹤0.01% 3729
2023
Q2 		$4.2K Sell
824
-1,290
-61% -$6.95K ﹤0.01% 4411
2023
Q1 		$11.6K Buy
2,114
+1,234
+140% +$6.53K ﹤0.01% 4069
2022
Q4 		$4.04K Sell
880
-577
-40% -$2.93K ﹤0.01% 4324
2022
Q3 		$9K Sell
1,457
-216
-13% -$1.22K ﹤0.01% 4134
2022
Q2 		$7K Buy
1,673
+1,517
+972% +$6.92K ﹤0.01% 4229
2022
Q1 		$1K Buy
+156
New +$993 ﹤0.01% 4862
2021
Q3 		– Sell
-4
Closed – – 5128
2021
Q2 		$0 Buy
+4
New +$43 ﹤0.01% 4973

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fidelity Investments's ZVRA Position: Q1 2026 in Review

Fidelity Investments increased its Zevra Therapeutics (ZVRA) stake by 34% in Q1 2026, buying an estimated $7.38M and bringing the position to 3,211,877 shares worth $29.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Fidelity Investments first reported a position in ZVRA in Q2 2021 and has held it in 18 quarters since. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Fidelity Investments held 3,211,877 shares of Zevra Therapeutics worth $29.9M as of Q1 2026.
  • Fidelity Investments bought 818,384 Zevra Therapeutics shares in Q1 2026, an estimated $7.38M.
  • Zevra Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1618 holding.
  • Fidelity Investments first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.